However, our study did leave some areas unexplored: for example, we did not examine specific targets for the downstream regulation of trophoblast proliferation by the glycolytic pathway, and we were not able to perform intervention studies of the use of PKM2 agonists on animal models of preeclampsia. Here, PKM is linked to preeclampsia.